CD38 and myelodysplastic syndrome: This study further found that MDS patients with CD7+ or CD34+CD38 dim/− phenotype exhibit a significantly reduced PLR, suggesting an interaction between abnormal immune phenotype and inflammatory response, which may be related to the immune escape mechanism of their LSCs.